These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2834766)

  • 1. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.
    Marazziti D; Perugi G; Deltito J; Lenzi A; Maremmani I; Placidi GF; Cassano GB
    Psychiatry Res; 1988 Feb; 23(2):229-37. PubMed ID: 2834766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression.
    Nemeroff CB; Knight DL; Krishnan RR; Slotkin TA; Bissette G; Melville ML; Blazer DG
    Arch Gen Psychiatry; 1988 Oct; 45(10):919-23. PubMed ID: 2844132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.
    Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E
    Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.
    DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S
    Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.
    DeMet EM; Chicz-DeMet A; Bell KM; Reist C; Gerner RH
    Psychiatry Res; 1990 Dec; 34(3):303-13. PubMed ID: 1963693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine binding as a predictor of fluoxetine response in depressed patients.
    Castrogiovanni P; Di Muro A; Marazziti D
    Neuropsychobiology; 1995; 31(2):64-7. PubMed ID: 7760987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls.
    Szádóczky E; Falus A; Németh A; Teszéri G; Moussong-Kovács E
    J Affect Disord; 1991 Aug; 22(4):179-84. PubMed ID: 1658102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelets possess multiple [3H]imipramine binding sites.
    Ieni JR; Zukin SR; Van Praag HM
    Eur J Pharmacol; 1984 Nov; 106(3):669-72. PubMed ID: 6097465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression.
    Slotkin TA; Whitmore WL; Barnes GA; Krishnan KR; Blazer DG; Knight DL; Nemeroff CB
    Biol Psychiatry; 1989 Mar; 25(6):687-91. PubMed ID: 2538161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression.
    Husain MM; Knight DL; Doraiswamy PM; Figiel GS; McDonald WM; Boyko OB; Krishnan KR; Nemeroff CB
    Biol Psychiatry; 1991 Apr; 29(7):665-70. PubMed ID: 1647227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.
    DeMet EM; Bell KM; Reist C; Gerner RH; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):315-29. PubMed ID: 1963694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.